-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Initiates Coverage On Definium Therapeutics with Buy Rating, Announces Price Target of $75

Benzinga·08/18/2026 09:06:53
Listen to the news
B of A Securities analyst Tazeen Ahmad initiates coverage on Definium Therapeutics (NASDAQ:DFTX) with a Buy rating and announces Price Target of $75.